Home

Első típus elárul Normalizálás teva sec filings Tervezett koponya szén

TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed  2022-05-03
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03

Teva Announces New Environmental, Social and Governance (ESG) Strategy and  Goals in 2020 Report | Business Wire
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire

Teva- Pharmaceutical Industries (TEVA) Részvényárfolyam-történet | wallmine
Teva- Pharmaceutical Industries (TEVA) Részvényárfolyam-történet | wallmine

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Capital Research Global Investors increases ownership in TEVJF / Teva  Pharmaceutical Industries Ltd.
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Neth 10/01/2026 3.150 Bond
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond

Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha

DEF 14A
DEF 14A

Teva won't say whether R&D cuts include layoffs; Cipla inks deal for  Iranian plant; | Fierce Pharma
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma

Teva: Avoid (NYSE:TEVA) | Seeking Alpha
Teva: Avoid (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by SG  Americas Securities LLC - MarketBeat
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by SG Americas Securities LLC - MarketBeat

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

Teva Pharma reserves $520 million for FCPA settlement | The FCPA Blog
Teva Pharma reserves $520 million for FCPA settlement | The FCPA Blog

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

DEF 14A
DEF 14A

SEC Subpoena For Teva | The FCPA Blog
SEC Subpoena For Teva | The FCPA Blog

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical  Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga

DEF 14A
DEF 14A

Form 10-K
Form 10-K

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd. (NYSE) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd. (NYSE) Stock

TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical  Industries Ltd (TLV) Stock
TEVA Institutional Ownership and Shareholders - Teva Pharmaceutical Industries Ltd (TLV) Stock

Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce  Pharma
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma

TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical  Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
TEVA PHARMACEUTICAL INDUSTRIES LTD (FormDEF 14A) - Teva Pharmaceutical Indus (OTC:TEVJF), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga

Form 10-K
Form 10-K

Teva looks to amp up research collaborations, CEO says
Teva looks to amp up research collaborations, CEO says